CALABASAS, Calif., Feb. 8, 2006 (PRIMEZONE) -- Aspyra, Inc. (AMEX:APY) today announced that President and Chief Executive Officer Steven M. Besbeck will be presenting at the Deutsche Bank Small Cap Growth Conference on Friday, Feb. 17, 2006, at the Ritz-Carlton, 280 Vanderbilt Beach Road, Naples, Fla., at 10:30 a.m. Eastern time.
During the presentation, which can be heard via live webcast at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=W196606&item_id=1209092, Mr. Besbeck will provide an overview of Aspyra's business activities and discuss his vision for the Company's future. The webcast will be archived for 90 days.
"Aspyra's transformation into a newly formed Company resulting from the recently completed merger of Creative Computer Applications, Inc., (Formerly AMEX: CAP) and StorCOMM, Inc., brings together a broad portfolio of clinical and diagnostic data management solutions targeting the Health Care Information Technology (HCIT) market," stated President and Chief Executive Officer Steven M. Besbeck. "This has opened the door to new product opportunities that position Aspyra for anticipated growth. We are pleased that we have been invited by conference organizers to introduce Aspyra to members of the investment community."
Senior executives from approximately 100 companies will make presentations during the three-day conference. They also will participate in one-on-one meetings with institutional investors who follow the healthcare industry.
About Aspyra, Inc.
Aspyra is a global provider of clinical and diagnostic information solutions for the healthcare industry. We have accumulated over 35 years of industry experience, specializing in enterprise-wide systems for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers, orthopedic environments and pharmacies. Our highly scalable products may be installed as standalone or integrated to provide a single-vendor solution. For more information on Aspyra, its products and services, visit www.aspyra.com.
Safe Harbor Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra's markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: whether the combined company will realize the potential benefits of the merger; the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.